A new study suggests that Paxlovid, a five-day antiviral treatment for COVID-19, may not provide significant protection against hospitalizations and all-cause deaths in vaccinated older adults. The research findings contradict previous claims that the medication was effective in reducing severe cases of COVID-19 in high-risk groups.
Source: https://www.washingtonpost.com/wellness/2025/03/05/paxlovid-hospitalizations-deaths-older-adults-study